Radiation-Induced Coronary Artery Disease

Area of Science:

• Cardiology
• Oncology
• Radiation Oncology

Background:

• Cancer survivors receiving chest radiation therapy are at risk for a unique form of coronary artery disease.
• Radiation-induced coronary artery disease (RICAD) often manifests years after treatment, even in young patients lacking traditional cardiovascular risk factors.
• RICAD pathogenesis involves chronic inflammation and fibrosis, differentiating it from typical atherosclerosis.

Purpose of the Study:

• To highlight radiation-induced coronary artery disease (RICAD) as a significant concern in cancer survivors.
• To emphasize the distinct clinical presentation and pathophysiology of RICAD.
• To guide clinicians on the recognition and management of RICAD.

Main Methods:

• Review of existing literature and clinical observations regarding radiation-induced cardiovascular complications.
• Analysis of the unique pathological mechanisms underlying RICAD.
• Discussion of clinical presentation, diagnostic considerations, and therapeutic approaches for RICAD.

Main Results:

• RICAD is a recognized complication following mediastinal radiation therapy.
• Presentation is often delayed, occurring years to decades post-radiation.
• Patients may lack conventional cardiovascular risk factors, presenting a diagnostic challenge.

Conclusions:

• A high index of suspicion for RICAD is crucial in cancer survivors with a history of chest radiation.
• Management strategies should consider the specific inflammatory and fibrotic nature of RICAD.
• Medical therapy and percutaneous coronary intervention are key treatment modalities when indicated.